Peter Greenleaf

Director; Director, Chief Executive Officer · 4 filings · Latest: Apr 2, 2026

Aurinia Pharmaceuticals Inc.

Pelthos Therapeutics Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
AUPH	PETER GREENLEAF	—	May 11, 2026	Proposed Sale	$15.84	3,136,201	$49.7M	—	May 11 8:11 PM
PTHS	Peter Greenleaf	Director	Apr 2, 2026	Sale	$20.92	797	$16.7K	24,681	Apr 6 9:01 PM